Atezolizumab
Product Specifications
CAS Number
1380723-44-3
Target
Apoptosis, Autophagy, PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Autophagy, Immunology/Inflammation, Apoptosis
Purity
0.993
Bioactivity
Atezolizumab is an antibody inhibitor, a humanized monoclonal antibody, IgG1, which targets PD-L1 and blocks the interaction of PD-L1 with PD-1. Atezolizumab has antitumor activity and promotes T-cells to attack tumor cells.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2328637-01 20 µg
Recombinant human PALLD Protein, N-MBP & C-His (HEK293)
Sign In for Pricing
View Details orb2328637-02 50 µg
Recombinant human PALLD Protein, N-MBP & C-His (HEK293)
Sign In for Pricing
View Details orb2328637-03 100 µg
Recombinant human PALLD Protein, N-MBP & C-His (HEK293)
Sign In for Pricing
View Details 
orb3087086 200 µL
Oryzias latipes Keratin, type I cytoskeletal 13 Rabbit Polyclonal Antibody (Fluoro647)
Sign In for Pricing
View Details